Hiroaki Kanzaki

1.0k citations
19 papers · 164 indexed · h-index 7
Topics
Hepatocellular Carcinoma Treatment and Prognosis (8 papers)Cancer, Hypoxia, and Metabolism (5 papers)Cancer Mechanisms and Therapy (4 papers)
Partner nations
JapanUnited StatesSweden

In The Last Decade

Hiroaki Kanzaki

17 papers receiving 162 citations

Peers

Hiroaki Kanzaki
Comparison fields: 5 of 39
  • Molecular Biology 76
  • Hepatology 66
  • Cancer Research 44
  • Pulmonary and Respiratory Medicine 38
  • Epidemiology 37
Replace Wen‐Bin Ding with:
Wen‐Bin Ding China
Carmen Andreu-Oller Spain
Kengo Kanayama Japan
Ruibao Liu China
Joseph Hreiki United States
Takashi Mineo Japan
Valentina Burgio Italy
Jinlong Song China
Erik Ramon‐Gil United Kingdom
Hiroaki Kanzaki relative to Wen‐Bin Ding China Wen‐Bin Ding's profile →
Citations per field
00.5×
Wen‐Bin Ding · 1×
Citations per year

Countries citing papers authored by Hiroaki Kanzaki

Since Specialization
Citations

This map shows the geographic impact of Hiroaki Kanzaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Kanzaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Kanzaki more than expected).

Fields of papers citing papers by Hiroaki Kanzaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Kanzaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Kanzaki. The network helps show where Hiroaki Kanzaki may publish in the future.

Co-authorship network of co-authors of Hiroaki Kanzaki

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Kanzaki. A scholar is included among the top collaborators of Hiroaki Kanzaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Kanzaki. Hiroaki Kanzaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 0
2 2
3 0
4 2
5 2
6 2
7 8
8 10
9 2
10 1
11 1
12 15
13 43
14 5
15 2
16 29
17 6
18 33
19 1

About Hiroaki Kanzaki

Hiroaki Kanzaki is a scholar working on Hepatology, Cancer Research and Internal Medicine, having authored 19 papers that have together received 164 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Cancer Mechanisms and Therapy (4 papers). The work is most often cited by research in Hepatology (66 citations), Cancer Research (44 citations) and Pathology and Forensic Medicine (22 citations). Hiroaki Kanzaki has collaborated with scholars based in Japan, United States and Sweden. Frequent co-authors include Tetsuhiro Chiba, Naoya Kato, Masato Nakamura, Kengo Kanayama, Yuko Kusakabe, Sadahisa Ogasawara, Tomoko Saito, Soichiro Kiyono, Shingo Nakamoto and Kazufumi Kobayashi. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026